Samal, Zuhara A.

HRN: 06-81-24  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/07/2025
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/07/2025
11/14/2025
IV
600mg
QID
Diabetic Foot
Checking Initial Appropriateness 
11/07/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
11/07/2025
11/14/2025
IV
4.5g
Q8h
DM Foot
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: